Catyalyst Pharmaceutical Partners (CPRX) Posts Q4 Loss of 10c/Share
Catyalyst Pharma
ceutical Partners (NASDAQ: CPRX) reported Q4 EPS of ($0.10), $0.04 worse than the analyst estimate of ($0.06).
For earnings history and earnings-related data on Catyalyst Pharmaceutical Partners (CPRX) click here.
ceutical Partners (NASDAQ: CPRX) reported Q4 EPS of ($0.10), $0.04 worse than the analyst estimate of ($0.06).For earnings history and earnings-related data on Catyalyst Pharmaceutical Partners (CPRX) click here.